HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hubert H Fernandez Selected Research

Cholinesterase Inhibitors (Anticholinesterases)

10/2016Current Understanding of Psychosis in Parkinson's Disease.
11/2003Pharmacotherapy of dementia with Lewy bodies.
1/2003Treatment of psychosis in Parkinson's disease: safety considerations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hubert H Fernandez Research Topics

Disease

92Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2002
19Psychotic Disorders (Schizoaffective Disorder)
01/2021 - 01/2002
16Dyskinesias (Dyskinesia)
01/2022 - 01/2003
13Dystonia (Limb Dystonia)
07/2021 - 04/2005
12Movement Disorders (Movement Disorder)
01/2019 - 06/2002
11Parkinsonian Disorders (Parkinsonism)
01/2022 - 11/2003
9Tremor (Tremors)
11/2018 - 01/2003
8Torticollis (Wryneck)
07/2021 - 01/2011
7Hallucinations (Hallucination)
01/2021 - 01/2002
6Tardive Dyskinesia
01/2022 - 01/2017
6Pain (Aches)
01/2020 - 01/2011
5Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019 - 10/2003
5Dementia (Dementias)
10/2016 - 06/2002
5Essential Tremor (Essential Tremors)
01/2014 - 07/2006
4Hypokinesia (Bradykinesia)
01/2017 - 12/2009
4Fatigue
11/2015 - 01/2003
4Cognitive Dysfunction
03/2015 - 11/2003
4Blepharospasm
01/2014 - 01/2008
4X-Linked Torsion Dystonia 3
01/2011 - 01/2010
3Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 01/2009
3Infections
06/2018 - 04/2005
2Alzheimer Disease (Alzheimer's Disease)
12/2019 - 05/2006
2Hypotension (Low Blood Pressure)
01/2019 - 01/2003
2Mental Disorders (Mental Disorder)
03/2017 - 06/2007
2Disease Progression
05/2014 - 08/2009
2Stroke (Strokes)
05/2014 - 11/2011
2Deglutition Disorders (Dysphagia)
01/2013 - 01/2011
2Dizziness (Lightheadedness)
01/2011 - 01/2003
2Schizophrenia (Dementia Praecox)
10/2004 - 01/2002
2Sleepiness
11/2003 - 01/2003
1Epilepsy (Aura)
07/2021
1Edema (Dropsy)
01/2021
1Urinary Tract Infections (Urinary Tract Infection)
01/2021
1Neuralgia (Stump Neuralgia)
01/2020
1Confusion (Bewilderment)
01/2020
1Atrial Fibrillation
01/2019
1Frailty
11/2018
1Autonomic Nervous System Diseases (Dysautonomia)
11/2018
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
03/2017
1Prodromal Symptoms
01/2017
1Secondary Parkinson Disease (Secondary Parkinsonism)
12/2014

Drug/Important Bio-Agent (IBA)

28Levodopa (L Dopa)FDA LinkGeneric
01/2022 - 06/2002
14Pharmaceutical PreparationsIBA
01/2020 - 01/2002
12Antipsychotic Agents (Antipsychotics)IBA
01/2019 - 01/2002
11Dopamine Agonists (Dopamine Agonist)IBA
01/2021 - 10/2003
9Carbidopa (Lodosyn)FDA LinkGeneric
07/2018 - 03/2013
9Quetiapine Fumarate (Seroquel)FDA Link
01/2009 - 06/2002
7incobotulinumtoxinAFDA Link
01/2020 - 01/2011
7Type A Botulinum Toxins (Botox)FDA Link
01/2020 - 01/2008
7Botulinum Toxins (Botulinum Toxin)IBA
01/2020 - 01/2008
6Clozapine (Clozaril)FDA LinkGeneric
01/2005 - 01/2003
5Dopamine (Intropin)FDA LinkGeneric
01/2021 - 12/2007
4deutetrabenazineIBA
01/2022 - 01/2017
4Proteins (Proteins, Gene)FDA Link
12/2019 - 01/2007
3levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
07/2018 - 04/2016
3SuspensionsIBA
07/2018 - 04/2016
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2017 - 12/2002
3Cholinesterase Inhibitors (Anticholinesterases)IBA
10/2016 - 01/2003
3Dopamine Agents (Dopaminergic Agents)IBA
01/2016 - 10/2003
3rasagiline (Azilect)FDA Link
11/2015 - 05/2007
3Monoamine Oxidase (MAO)IBA
12/2007 - 01/2007
2pimavanserinIBA
01/2021 - 01/2020
2Biological ProductsIBA
12/2019 - 01/2017
2Dopamine Receptors (Dopamine Receptor)IBA
01/2019 - 01/2003
2Dopamine AntagonistsIBA
01/2017 - 10/2003
2abobotulinumtoxinAFDA Link
12/2015 - 01/2008
2Testosterone (Sustanon)FDA Link
01/2014 - 05/2006
2Cholinergic Antagonists (Anticholinergics)IBA
11/2009 - 10/2003
2Selegiline (E250)FDA LinkGeneric
05/2007 - 09/2006
1Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
01/2022
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
07/2021
1AMPA Receptors (AMPA Receptor)IBA
07/2021
1Excitatory Amino Acid AntagonistsIBA
07/2021
1perampanelIBA
07/2021
1Designer DrugsIBA
01/2021
1Cholinergic ReceptorsIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
12/2019
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
12/2019
1Cytochrome P-450 CYP2D6 InhibitorsIBA
12/2019
1SynucleinsIBA
12/2019
1PowdersIBA
01/2019
1Dopa DecarboxylaseIBA
01/2019
1TabletsIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1coenzyme Q10 (CoQ10)IBA
05/2014
1AntioxidantsIBA
05/2014

Therapy/Procedure

42Deep Brain Stimulation
01/2022 - 04/2005
27Therapeutics
01/2022 - 10/2003
10Home Nursing (Nursing, Home)
10/2016 - 01/2002
5Drug Therapy (Chemotherapy)
01/2022 - 01/2003
5Injections
01/2020 - 01/2011
3Gastric Bypass (Roux-en-Y Gastric Bypass)
07/2018 - 03/2013
3Activities of Daily Living (ADL)
01/2017 - 10/2008
2Length of Stay
01/2020 - 06/2010
2Electrodes (Electrode)
01/2014 - 04/2006
2Nerve Block (Nerve Blocks)
01/2011 - 01/2011
1Microelectrodes
01/2020
1Precision Medicine
12/2019
1Replantation
06/2018
1Retreatment
12/2015